• Cancel
    Date：2025-03
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=873

    Recently, Geneus Technologies, a leading domestic company in nanopore sequencing technology, announced the completion of a nearly RMB 100 million B++ round of financing. This round of funding was led by CDBT Group, with participation from Si Chuan Venture

  • Cancel
    Date：2025-02

    Exclusive Financial Advisor to QL Biopharm

  • Cancel
    Date：2025-01
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=910

    CEC Capital announced today that its GP/LP service team, dedicated to the private equity secondary market, has successfully completed two significant transactions involving the exit of existing shares. These deals enabled clients to achieve large-scale li

  • Cancel
    Date：2024-12
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=865

    Recently, BridgeDP, an emerging startup in the embodied intelligence sector, announced it has raised several tens of millions of RMB in its angel financing. The round was co-led by Zhengxuan Investment and Fosun Capital. CEC Capital acted as the exclu

  • Cancel
    Date：2024-12
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=860

    Xiaoyu Bot, the first robotics company in the Xiaomi ecosystem to leverage large model technology, recently announced the closing of its Series A financing, raising 100 million RMB. The round was exclusively funded by the Beijing Information Industry Deve

  • Cancel
    Date：2024-10
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=854

    Recently, Dingzhi Dental, a leading brand and expert in complex dental implants in China, announced the closing of its Series A financing, raising several hundred million RMB, with Eight Roads as the sole investor. CEC Capital served as the exclusive

  • Cancel
    Date：2024-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=842

    MicroCyto announced that it has raised over 300 million yuan in Series A financing. The round was led by Beijing Jingguorui Investment, with participation from Beijing Medical and Health Industry Investment Fund, Shenzhen Capital Group, and Hebei Producti

  • Cancel
    Date：2024-07
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=839

    MoonBiotech announced that it has recently completed a RMB 300 million Series C+ financing, solely invested by SDIC JULI Investment Management Co., LTD. This financing round follows the Series C funding involving SDIC Venture Capital, marking another inst

  • Cancel
    Date：2024-05
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=775

    Recently, Blue Sail Medical (002382.SZ) announced that its cardiovascular and cerebrovascular business unit, Blue Sail Biosensors, has raised a total of RMB 1 billion in funding. The Series A2 round introduced an additional RMB 100 million, following a RM